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AVARIETY of strains of mice respond to the administration of chemical
carcinogens at birth with the development of a bigh incidence of malignant
lymphomas and of certain other tumours (Pietra, Spencer and Shubik, 1959;
Pietra, Rappaport and Shubik, 1961; K'elly and O'Gara, 1961 ; Fiore-Donati et
al., 1961; Roe, Rowson and Salaman, 1961; Toth, Rappaport and Shubik,
1962 ; Doell and Carnes, 1962). The carcinogen 7,12-dimethylbenz(a)anthracene
(DMBA) was found to be a very potent leukaemogenic agent for mice when
injected subcutaneously at birth (Pietra, Spencer and Shubik, 1959; Pietra,
Rappaport and Shubik, 1961 ; Roe, Rowson and Salaman, 1961 ; Toth, Rappa-
port andShubik, 1962). Its effects at different dose levels and on mice ofdifferent
age have been studied (Toth, Rappaport and Shubik, 1963).
In adult rats of various strains subcutaneous administration of DMBA was
found to induce mainly sarcomas at the site ofinjection (Davenport et al., 1941 ;
Berenblum, 1949) while administration ofthis carcinogen by other routes resulted
mainly in the development of mammary tumours (Geyer et al., 1951 ; Howell,
1960 ; Huggins, Grand and BriHantes, 1961 ; Boyland and Sydnor, 1962).
The present experiment was undertaken to investigate the effect of DMBA
in Lewis rats, when administered subcutaneously at birth at different dose levels.
MATERIALS AND METHODS
Lewis inbred rats originally obtained tbxough the courtesy of Dr. Kurt Stern,
Department of Pathology, University of Illinois, Chicago, and since 1961 bred in
our laboratory by brother-to-sister mating, were used. Each litter was housed
with its mother untfl it was weaned, then separated according to sex. All rats
were housed in plastic cages with granular ceRulose bedding in groups of five,
and were given Rockland diet in pellets and tap water ad libitum.
The carcinogen used was 7,12-dimethy1benz(a)anthracene (DMBA) (Eastman
Organic Chemicals), purifiedbycbxomatography on magnesia/Celite. It was dis-
solved in tri-n-caprylin (trioctanoin) (Eastman Organic Chemicals), purified bv
vacuum distillation, at different concentrations, such that the desired dose of
DMBA was always contained in 0-05 ml. of tri-n-caprylin. The animals were
injected subcutaneously in the interscapular area with a tuberculin syringe, using
a 30 gauge needle. The injections were made less than 24 hours after birth oftheCARCINOGENESIS IN RATS INJECTED AT BIRTH 541
animals. Surgical gloves were worn to handle the newborns in an attempt to
niinimise their rejection by the mothers. Six groups of newborn rats received a
single injection ofDMBA, in the following doses: 1000, 100, 75, 50, 25 and 10 Itg.
A control group was given a single injection of 0-05 ml. of tri-n-caprylin, and
another control group of 50 females and 50 males was kept untreated. The
number of injected animals and the number of survivors at weaning (five weeks)
are shown in Table 1. The latent period of visceral tumours was determined
from the date of treatment to the time of death, while the latent period of skin
and subcutaneous tumours were based on the time at which thev were first
recognised grosslv in the live animal.
The experimental and control animals were carefully checked and weighed at
weekly intervals and the skin and subcutaneous changes were recorded on grapil
paper. The animals were allowed to die spontaneously, or were killed with ether
when found in poor conditions. A complete necropsy was performed on all
animals except on one tricaprylin injected male and one untreated male, which
were lost thxough cannibalism. All organs were examined macroscopically and
were fixed in 10 per cent buffered formalin. Tissues which showed gross patho-
logic changes were studied histologically using haematoxylin-eosin stain with the
addition ofspecial methods, when necessary.
RESULTS
The survival rates at weaning, recorded in Table 1, show a high mortality in
all injected groups, includingtri-n-caprylin controls, with no apparent relationship
to the toxicity of IDMBA. Handling and injecting newborn animals is known to
cause cannibalism by their mothers in other species also, resulting in a high death
rate. The survival rates after weaning are also recorded in Table 1. It is
apparent that only the 1000 /,tg. dose of DMBA significantly reduced the survival.
In the course of the experiment both treated and control groups suffered from
sporadic tracheobronebitis with associated lung abscesses which were responsible
for the death of several animals.
The number and latent period of all observed tumours are given in Table 1.
Treatment with DMBA resulted in the induction of subcutaneous sarcomas at the
site of injection. The number, incidence and latent period of these sarcomas are
shown in Table I and Fig. 1. The cumulative incidences for both sexes were
the following 1000 /,tg. : 75-0 per cent ; 100 /,tg. : 1-7-3 per cent ; '15 /tg. :
7-8 per cent ; 25 jig. : 5-0 per cent. No such tumour was found in the groups
treated with 50 and 10 jig. of DMBA, nor in the tri-n-caprylin injected and in
the untreated animals. Furthermore, as can be seen in Fig. 1, decreasing doses
of DTNIBA resulted in a gradual prolongation of latent periods of the induced
sarcomas.
These subcutaneous sarcomas were located on the back or on tl-ie sides of the
chest, round or ovoid in shape with larger diameter ranging from 10 to 70 mm.
Few of them grossly appeared necrotic and ulcerated. The tumours were rati'ler
firm and their cut surface appeared whitish and often haemorrhagic.
Histologically these tumours were spindle cell sarcomas with more or less
(lensely cellular areas, with rare mitoses and a moderate amount ofreticulin fibres.
In some instances mainly in the early lesions markedly dilated blood vessels aiid
haemorrhagic areas were found; some areas showed haemangiomatous or liae-542 B. TOTH AND P. SHUBIK
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mangiosarcomatous features. Only in a single case was a metastasis found in
the lung.
In addition, a number ofotherneoplasms were found in the treated and control
animals as hsted in Table I. Since a few such tumours occurred in all groups,
they could not be related to the treatment.
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FIG. I.-Cumulative percentage of induced sarcomas (calculated on the number of rats at
weaning).
DIESCUSSION
Subcutaneous injection of DMBA in adult rats is known to result mainly in
the induction of subcutaneous sarcomas (Davenport et al., 1941 ; Berenblum,
1949) while the administration of DMBA by other routes in adult rats of several
strains yields other types of neoplasms, mostly mammary tumours (Geyer et al.,
1951; Howell, 1960; Huggins, Grand and Brillantes, 1961; Boyland and
Sydnor, 1962).
The present study was undertaken to investigate the response of newborn
rats to this carcinogen. This was stimulated by the finding that in adult Swiss
mice subcutaneous injection of DMBA induces a considerable incidence of sub-
cutaneous sarcomas while the same treatment in newborns gives rise to a high
incidence of malignant lymphomas and of lung adenomas but only to very few
sarcomas at the site of injection (Toth,.Rappaport and Shubik, 1963). The in-
duction of a high percentage of lymphomas and very few sarcomas following544 B. TOTH AND P. SHUBIK
injection of DMBA in newborn mice of various strains was also reported (Pietra
Spencer and Shubik, 1959 ; Pietra, Rappaport and Shubik, 1961 ; Roe, Rowson
and Salaman, 1961 ; Toth, Rappaport and Shubik, 1962).
The present findings show that in Lewis rats, even when DMBA is injected at
birth, subcutaneous sarcoma induction represents the only unequivocal onco-
genic response. It was also demonstrated that with decreasing doses of DMBA,
the number and incidence of these tumours diminish, while their latent periods
increase. It seems clear from these results that a directdose-responserelationship
exists between dosage of carcinogen and incidence of subcutaneous sarcomas.
In the groups injected with 50, 25 and 10 #g. of DMBA the number of animals
was too smaH for quantitative evaluation of the tumour incidence.
Although only two malignant lymphomas were observed in the treated ra-ts,
none was observed in the controls. Such an occurrence is impossible to evaluate,
although one cannot exclude the possibility that the lymphomas observed were
related to the treatment. The results obtained, however, contrast sharply with
those obtained in Swiss mice where the most outstanding aspect of the response
was the occurrence of many lymphomas.
Thisprovides anexample of a definite variance in the reaction to acarcinogenic
stimulus under identical experimental conditions between mice of several strains
and Lewis rats. It appears that in Lewis rats treated subcutaneously at birth
DMBA exerts only a localcarcinogenic action, while in mice in the same conditions
DMBA is essentially a remotely acting carcinogen leading to the developmewf, of
malignant lymphomas and lung adenomas. In adult mice, on the other hand,
DMBA induces tumours mainly at the site of application. In this respect new-
born rats respond to the carcinogen more like adult Swiss mice.
A variety ofpossible interpretations of these experiments can be made. It is
thought by some workers in this field that aR lymphomas induced in mice are
essentially viral inorigin and that thoselymphomas obtained with chemical carci-
nogens and with radiations result from an
" activation
" of a latent virus. Such
a possibility is supported by the demonstration that a filterable leukaemogenic
agent may be obtained from both radiation (Gross, 1959 ; Lieberman andKaplan,
1959) and chemically (Toth, 1963) inducedlymphomas. Recently we have found
that the newborn mouse metabolizes or eliminates DMBA more slowly than the
adult mouse (Domsky et al., 1963), providing for an additional explanation al-
though by no means excluding a suppression of immunological response as the
possible factor. The fact that the Lewis rat does not develop lymphomas in the
same way as the Swiss mouse in our studies could certainly lend weight to this
general view-point and the probability that this animal does not possess a latent
virus certainly comes to mind. On the other hand, the four-week-old mouse and
the Lewis rat are extremely sensitive to the formation of sarcomas at the site of
injection. It would appear, therefore, only logical to consider that these tumours
do not require the intervention of an additional factor which might be viral in
nature. The hypothetical analysis of these occurrences, while leading to the
conclusion that a viral factormight well be involved inthe induction oflymphomas
by chemical carcinogens, equally leads to a conclusion that the other tumours
seen in response to these agents probably do not require such stimulation. Once
again, therefore, it becomes apparent that it is dangerous indeed to generalize
from one type of tumour induction in general, and that it is vital that each in-
stance be considered in detail in its own context.CARCINOGENESIS IN RATS INJECTED AT BIRTH 545
SUMMARY
A single subcutaneous injection of 7,12-dimethylbenz(a)antbracene in tri-
caprylin was administered in the interseapular region to newborn Lewis rats.
Doses of 1000, 100) 751 50. 25 and 10 ltg. were given, and tricaprylin-treated and
untreated controls were also observed. A clirect dose-response relationship was
established between the dose of DMBA administered and the number of sarcomas
induced at the site of injection. The latent period of these tumours increased
with decreasing doses ofcarcinogen. Other tumours were found in both treated
and untreated rats ; their appearance was not related to the treatment.
The authors wish to acknowledge the technical help of Mrs. Irene Boreisha.
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